Previous Page  2 / 5 Next Page
Information
Show Menu
Previous Page 2 / 5 Next Page
Page Background

American Journal of Ethnomedicine

ISSN: 2348-9502

April 16-17, 2018

Amsterdam, Netherlands

Pharmacognosy 2018

Page 16

6

th

Edition of International Conference on

Pharmacognosy and

Medicinal Plants

C

oncussive head injury (CHI) is quite common in military

personnel during combat operation for which no suitable

therapy exists till today. In this investigation, we report

that nanodelivery of traditional Chinese medicine, DL-3-n-

butylphthalide (DL-NBP) in CHI that was the most effective in

reducing brain pathology in CHI if given 2 and 4 h after an 8 h

injury or 8 and 12 h after 24 h trauma. Since CHI induces severe

brain ischemia and oxidative stress, in this investigation we also

examined the effects of TiO

2

-DL-NBP on regional cerebral blood

flow (CBF) and brain pathology in our rat model of CHI. CHI was

inflicted by dropping aweight of 114.6 g on the right parietal skull

bone over a distance of 20 cm in anesthetized rats resulting an

impact of 0.224 N on the skull surface. This impact induces brain

pathology from over 4 h to 24 h. In separate groups of injured

animals, administration of TiO

2

-nanowired-NBP (40 or 60 mg/kg,

i.p.) 2h and 4 h after injury in 8 h survival group and 8 h and 12 h

after trauma in 24 h survival group. In the untreated and treated

groups, regional CBF (rCBF) in the cerebral cortex, hippocampus,

thalamus, hypothalamus, cerebellum and brainstem was

measured using [125]-Iodine labeled microspheres (15±0.6 µm

o.d.). Untreated CHI resulted in a progressive increase in brain

pathology, reduction in the rCBF (-30 to -50%) and development

of brain edema formation. TiO

2

-NBP resulted in significant

improvement in rCBF in all brain areas examined. On the other

hand, 80 to 100 mg/kg, dose of normal NBP is needed to induce

comparable c reduction in rCBF and brain pathology in CHI.

These observations show that nanodelivery of NBP has superior

neuroprotective effects in CHI, a feature require additional

investigation for clinical relevance.

Biography

Hari Shanker Sharma is the Director of Research (International Experimen-

tal Central Nervous System Injury & Repair, IECNSIR), University Hospital,

Uppsala University; Professor of Neurobiology (MRC), Docent in Neuro-

anatomy (UU) and is currently affiliated with Department of Surgical Sci-

ences, Division of Anesthesiology and Intensive Care Medicine, Uppsala

University, Sweden. On his research on brain pathology and neuroprotec-

tion in different models, he received prestigious awards from The Laerd-

al Foundation of Acute Medicine, Stavanger, Norway, in 2005 and Distin-

guished International Scientists Collaboration Award (DISCA) by National

Institute on Drug Abuse (NIDA), Baltimore, MD (2006–2008). His current

research is focused on the role of nanoparticles in neurodegeneration and

neuroprotection and nanodrug delivery for novel treatment strategies sup-

ported by European Aerospace Research and Development (EOARD), Lon-

don, UK and US Air Force Research Laboratory, Wright Patterson Air Force

Base, Dayton, OH, USA. He has published over 400 peer reviewed research

papers (H-index 41).

Sharma@surgsci.uu.se

Superior neuroprotective effects of

nanowired delivery of Chinese celery

extract DL-3-n-butylphthalide (DL-NBP) on

concussive head injury

Hari Shanker Sharma

Uppsala University Hospital, Sweden

Hari Shanker Sharma, Am J Ethnomed 2018, Volume 5

DOI: 10.21767/2348-9502-C1-004